Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05359250 · ClinicalTrials.gov registry record
Myocardial Injury and Dysfunction Associated With COVID-19 Vaccination
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 10
- Enrollment target
NCT05359250 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 10 participants.
The verdict
NCT05359250 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The overall goal of the study is to investigate the characteristics and potential mechanisms responsible for myocardial injury and dysfunction in patients after COVID-19 vaccination. Cardiac damage will be assessed with cardiac MRI and endomyocardial biopsy (EmBx) histopathology. Myocardial gene expression will be measured in RNA extracted from EmBxs mRNA abundance compared to nonfailing and failing control hearts.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-05-12 |
| Est. Completion | 2024-12-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05359250
The ClinicalTrials.gov registry entry for NCT05359250 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05359250 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05359250 about?
NCT05359250 is a clinical study titled "Myocardial Injury and Dysfunction Associated With COVID-19 Vaccination". The overall goal of the study is to investigate the characteristics and potential mechanisms responsible for myocardial injury and dysfunction in patients after COVID-19 vaccination. Cardiac damage will be assessed with cardiac MRI and endomyocardial biopsy (EmBx) histopathology. Myocardial gene exp...
What is the current status of trial NCT05359250?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2021-05-12. Estimated completion is 2024-12-30.
Who is sponsoring clinical trial NCT05359250?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.